Page 33 - Haematologica Vol. 109 - July 2024

SPOTLIGHT REVIEW ARTICLE - Coagulation factors and endothelial functionality C. Olgasi et al. References
1. Madhusudhan T, Kerlin BA, Isermann B. The emerging role of coagulation proteases in kidney disease. Nat Rev Nephrol. 2016;12(2):94-109.
2. Neubauer K, Zieger B. Endothelial cells and coagulation. Cell Tissue Res. 2022;387(3):391-398.
3. Italiano JE, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released. Blood. 2008;111(3):1227-1233.
4. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol. 1996;16(3):488-496.
5. Hirano M, Hirano K. Critical role of Rho proteins in myosin light chain di-phosphorylation during early phase of endothelial barrier disruption. J Physiol Sci. 2022;72(1):1-13.
6. Lin Y, Wozniak JM, Grimsey NJ, et al. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function. Proc Natl Acad Sci U S A. 2020;117(9):5039-5048.
7. Koller GM, Schafer C, Kemp SS, et al. Proinflammatory mediators, IL (interleukin)-1b, TNF (tumor necrosis factor) α, and thrombin directly induce capillary tube regression. Arterioscler Thromb Vasc Biol. 2020;40(2):365-377.
8. Catar R, Moll G, Hosp I, et al. Transcriptional regulation of thrombin-induced endothelial VEGF induction and proangiogenic response. Cells. 2021;10(4):910.
9. Radjabi AR, Sawada K, Jagadeeswaran S, et al. Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface. J Biol Chem. 2008;283(5):2822-2834.
10. Zhao B, Wu M, Hu Z, et al. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation. Signal Transduct Target Ther. 2020;5(1):117.
11. Zhou HJ, Tang T, Cui HJ, et al. Thrombin-triggered angiogenesis in rat brains following experimental intracerebral hemorrhage. J Neurosurg. 2012;117(5):920928.
12. Griffin CT, Srinivasan Y, Zheng YW, Huang W, Coughlin SR. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science. 2001;293(5535):1666-1670.
13. Li Z, Yin M, Zhang H, et al. BMX represses thrombin-PAR1- mediated endothelial permeability and vascular leakage during early sepsis. Circ Res. 2020;126(4):471-485.
14. Tsopanoglou NE, Andriopoulou P, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis: involvement of αvb3-integrin. Am J Physiol Cell Physiol. 2002;283(5):C1501-1510.
15. Zolotoff C, Puech C, Roche F, Perek N. Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage. Sci Rep. 2022;12(1):1-14.
16. Gumundsdottir IJ, Lang NN, Boon NA, et al. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J Am Coll Cardiol. 2008;51(18):1749-1756.
17. Terraube V, O’Donnell JS, Jenkins P V. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia. 2010;16(1):3-13.
18. Follenzi A, Benten D, Novikoff P, Faulkner L, Raut S, Gupta S. Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. J Clin Invest.
2008;118(3):935-945.
19. Cadé M, Muñoz-Garcia J, Babuty A, et al. FVIII regulates the
molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior. Cell Mol Life Sci. 2022;79(3):145.
20. Bhat V, Olmer M, Joshi S, et al. Vascular remodeling underlies rebleeding in hemophilic arthropathy. Am J Hematol. 2015;90(11):1027-1035.
21. Sun H, Yang M, Fung M, et al. Adult males with haemophilia have a different macrovascular and microvascular endothelial function profile compared with healthy controls. Haemophilia. 2017;23(5):777-783.
22. Manon-Jensen T, Tangada S, Bager C, et al. Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in hemophilia A patients: a secondary analysis of a randomized controlled trial. J Thromb Haemost. 2024;22(1):90-100.
23. Hossain A, Tauhid L, Davenport I, et al. LRP-1 pathway targeted inhibition of vascular abnormalities in the retina of diabetic mice. Curr Eye Res. 2017;42(4):640-647.
24. Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117(3):1071-1080.
25. Randi AM, Smith KE, Castaman G. von Willebrand factor regulation of blood vessel formation. Blood. 2018;132(2):132-140.
26. Xu H, Cao Y, Yang X, et al. ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery. Blood. 2017;130(1):11-22.
27. de Vries MR, Peters EAB, Quax PHA, Nossent AY. von Willebrand factor deficiency leads to impaired blood flow recovery after ischaemia in mice. Thromb Haemost. 2017;117(7):1412-1419.
28. Ishihara J, Ishihara A, Starke RD, et al. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019;133(24):2559-2569.
29. Ruf W, Yokota N, Schaffner F. Tissue factor in cancer progression and angiogenesis. Thromb Res. 2010;125(Suppl 2):S36-S38.
30. Mackman N, Brand K, Edgington TS. Lipopolysaccharide- mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991;174(6):1517-1526.
31. Unruh D, Horbinski C. Beyond thrombosis: the impact of tissue factor signaling in cancer. J Hematol Oncol. 2020;13(1):1-14.
32. Ruf W, Yokota N, Schaffner F. Tissue factor in cancer progression
and angiogenesis. Thromb Res. 2010;125(Suppl 2):S36-S38.
33. Giannarelli C, Alique M, Rodriguez DT, et al. Alternatively spliced
tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling. Circulation. 2014;130(15):1274-1286.
34. Van Den Berg YW, Van Den Hengel LG, Myers HR, et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A. 2009;106(46):19497-19502.
35. Kocatürk B, Van Den Berg YW, Tieken C, et al. Alternatively spliced tissue factor promotes breast cancer growth in a b1 integrin-dependent manner. Proc Natl Acad Sci U S A. 2013;110(28):11517-11522.
Haematologica | 109 July 2024
2047